1: Tabuchi Y, Kurebayashi Y. Effect of DS-4574, a novel peptidoleukotriene antagonist with mast cell stabilizing action, on acute gastric lesions and gastric secretion in rats. Jpn J Pharmacol. 1992 Dec;60(4):335-40. doi: 10.1254/jjp.60.335. PMID: 1287268.
2: Aibara S, Mori M, Iwamoto T, Chiba T, Tsukada W. Antagonistic action of DS-4574 against leukotrienes in guinea-pig smooth muscle. Arch Int Pharmacodyn Ther. 1991 Nov-Dec;314:147-59. PMID: 1668601.
3: Aibara S, Mori M, Iwamoto T, Tsubokawa M, Takamori H, Tsukada W. Effects of DS-4574, a new orally active antiallergic agent, in experimental allergic and inflammatory models. Jpn J Pharmacol. 1993 Apr;61(4):267-76. doi: 10.1254/jjp.61.267. PMID: 8320873.
4: Aibara S, Mori M, Tsukada W. Inhibitory effect of DS-4574 on leukotriene- or antigen-induced bronchoconstriction in guinea pigs. Int Arch Allergy Immunol. 1993;100(3):268-73. doi: 10.1159/000236423. PMID: 7680929.
5: Tabuchi Y, Furuhama K. Inhibitory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene receptor antagonism, on gastric acid secretion in rats. Eur J Pharmacol. 1994 Apr 1;255(1-3):229-34. doi: 10.1016/0014-2999(94)90102-3. PMID: 8026547.
6: Yamashika Y, Tabuchi Y, Kokue E. Antisecretory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene antagonism, on gastric acid secretion in the pig. Agents Actions. 1994 Mar;41(1-2):17-20. doi: 10.1007/BF01986387. PMID: 8079817.
7: Murayama N, Nakaoka M, Nomura H, Hakusui H. Radioimmunoassay for DS-4574, an antiallergic agent: development, evaluation, and application to human plasma samples. J Pharm Sci. 1994 Nov;83(11):1574-7. doi: 10.1002/jps.2600831111. PMID: 7891277.
8: Tabuchi Y, Kawarabayashi K, Furuhama K. Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats. Agents Actions. 1994 Mar;41(1-2):21-4. doi: 10.1007/BF01986388. PMID: 7521568.
9: Tabuchi Y, Kawarabayashi K, Komada T, Furuhama K. Protective effect of DS-4574 on gastric mucosal injury induced by acidified ethanol in rats. Eur J Pharmacol. 1993 Nov 30;250(1):197-9. doi: 10.1016/0014-2999(93)90644-w. PMID: 7907021.
10: Tabuchi Y, Furuhama K. Protective effect of DS-4574, a peptidoleukotriene receptor antagonist, against endotoxin-induced intestinal injury in rats. Eur J Pharmacol. 1995 Feb 6;273(3):281-4. doi: 10.1016/0014-2999(94)00739-t. PMID: 7737335.
11: Aibara S, Mori M, Tsubokawa M, Iwamoto T, Tsukada W. Antiallergic activity of 6-(2-cyclohexylethyl)-[1,3,4]thiadiazolo- [3,2-a]-1,2,3-triazolo-[4,5-d]pyrimidin-9(3H)-one (DS-4574) in rats. Int Arch Allergy Immunol. 1992;98(2):146-52. doi: 10.1159/000236178. PMID: 1379506.
12: Murayama N, Nakaoka M, Nomura H, Hakusui H. Radioimmunoassay for DS-4574, an anti-allergic agent: development, evaluation and application to human plasma samples. J Pharm Biomed Anal. 1995 Apr;13(4-5):671-3. doi: 10.1016/0731-7085(95)01302-2. PMID: 9696586.
13: Yokohama S, Miwa T, Aibara S, Fujiwara H, Matsumoto H, Nakayama K, Iwamoto T, Mori M, Moroi R, Tsukada W, et al. Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9(3H)-one derivatives. II. 6-Alkyl- and 6-cycloalkylalkyl derivatives. Chem Pharm Bull (Tokyo). 1992 Sep;40(9):2391-8. doi: 10.1248/cpb.40.2391. PMID: 1446361.